title: Computational studies on the interaction of ABO-active saccharides with the norovirus VA387 capsid protein can explain experimental binding data.
abstract: Norovirus strains are known to cause recurring epidemics of winter vomiting disease. The crystal structure of the capsid protein of VA387, a representative of the clinically important GII.4 genocluster, was recently solved in complex with histo-blood group A- and B-trisaccharides. However, the VA387 strain is known to bind also to other natural carbohydrates for which detailed structural information of the complexes is not available. In this study we have computationally explored the fit of the VA387 with a set of naturally occurring carbohydrate ligands containing a terminal alpha1,2-linked fucose. MD simulations both with explicit and implicit solvent models indicate that type 1 and 3 extensions of the ABO-determinant including ALe(b) and BLe(b) pentasaccharides can be well accommodated in the site. Scoring with Glide XP indicates that the downstream extensions of the ABO-determinants give an increase in binding strength, although the alpha1,2-linked fucose is the single strongest interacting residue. An error was discovered in the geometry of the GalNAc-Gal moiety of the published crystal structure of the A-trisaccharide/VA387 complex. The present modeling of the complexes with histo-blood group A-active structures shows some contacts which provide insight into mutational data, explaining the involvement of I389 and Q331. Our results can be applicable in structure-based design of adhesion inhibitors of noroviruses.
authors.affiliation: Biognos AB, Generatorsgatan 1, 40274 Gothenburg, Sweden.
authors.forename: Chaitanya A K
authors.initials: CA
authors.lastname: Koppisetty
authors.forename: Waqas
authors.initials: W
authors.lastname: Nasir
authors.forename: Francesco
authors.initials: F
authors.lastname: Strino
authors.forename: Gustaf E
authors.initials: GE
authors.lastname: Rydell
authors.forename: Göran
authors.initials: G
authors.lastname: Larson
authors.forename: Per-Georg
authors.initials: PG
authors.lastname: Nyholm
mesh_terms: D000017:ABO Blood-Group System / Q000737:chemistry* / Q000378:metabolism*; D001665:Binding Sites; D036022:Capsid Proteins / Q000737:chemistry* / Q000378:metabolism*; D002240:Carbohydrate Sequence; D003198:Computer Simulation; D006801:Humans; D066298:In Vitro Techniques; D008024:Ligands; D008958:Models, Molecular; D056004:Molecular Dynamics Simulation; D008969:Molecular Sequence Data; D029322:Norovirus / Q000737:chemistry* / Q000378:metabolism* / Q000472:pathogenicity; D009844:Oligosaccharides / Q000737:chemistry* / Q000378:metabolism*; D011485:Protein Binding; D012984:Software
chemical_list: D000017:ABO Blood-Group System; D036022:Capsid Proteins; D008024:Ligands; D009844:Oligosaccharides
references.citation: J Chem Inf Model. 2009 Dec;49(12):2749-60
references.pmid: 19994843
references.citation: Nat Med. 2003 May;9(5):548-53
references.pmid: 12692541
references.citation: J Virol. 2002 Dec;76(23):12335-43
references.pmid: 12414974
references.citation: J Virol. 2004 Mar;78(6):3035-45
references.pmid: 14990722
references.citation: Carbohydr Res. 2009 Nov 2;344(16):2217-28
references.pmid: 19758584
references.citation: J Comput Chem. 2003 Sep;24(12):1504-13
references.pmid: 12868113
references.citation: J Virol. 2008 Jun;82(11):5340-7
references.pmid: 18385236
references.citation: Carbohydr Res. 2005 Apr 11;340(5):1059-64
references.pmid: 15780270
references.citation: J Virol. 2008 Nov;82(21):10756-67
references.pmid: 18701592
references.citation: J Comput Chem. 2008 Mar;29(4):622-55
references.pmid: 17849372
references.citation: J Med Virol. 2005 Sep;77(1):116-20
references.pmid: 16032732
references.citation: Proteins. 2004 May 1;55(2):383-94
references.pmid: 15048829
references.citation: J Med Virol. 2008 Jul;80(7):1296-301
references.pmid: 18461617
references.citation: J Virol. 2007 Jun;81(11):5949-57
references.pmid: 17392366
references.citation: Gastroenterol Clin North Am. 2006 Jun;35(2):275-90, viii
references.pmid: 16880066
references.citation: Glycobiology. 2009 Mar;19(3):309-20
references.pmid: 19054801
references.citation: Gastroenterology. 2002 Jun;122(7):1967-77
references.pmid: 12055602
references.citation: J Virol. 2005 Jun;79(11):6714-22
references.pmid: 15890909
references.citation: J Comput Aided Mol Des. 2009 Dec;23(12):845-52
references.pmid: 19757090
references.citation: Virology. 2008 Sep 30;379(2):324-34
references.pmid: 18692213
references.citation: Proc Natl Acad Sci U S A. 2008 Jul 8;105(27):9175-80
references.pmid: 18599458
references.citation: J Biol Chem. 1995 Mar 3;270(9):4640-9
references.pmid: 7876235
references.citation: PLoS One. 2009;4(5):e5593
references.pmid: 19440360
references.citation: J Infect Dis. 2009 Sep 1;200(5):802-12
references.pmid: 19627248
references.citation: Proteins. 2006 Nov 15;65(3):712-25
references.pmid: 16981200
references.citation: Bioinformatics. 1999 Sep;15(9):767-8
references.pmid: 10498779
references.citation: J Clin Microbiol. 2007 Aug;45(8):2720-2
references.pmid: 17537929
references.citation: PLoS Med. 2008 Feb;5(2):e31
references.pmid: 18271619
references.citation: J Virol. 2005 Dec;79(24):15351-5
references.pmid: 16306606
references.citation: J Infect Dis. 2006 Nov 15;194(10):1422-7
references.pmid: 17054072